<DOC>
	<DOCNO>NCT01475370</DOCNO>
	<brief_summary>The purpose study assess safety OCV-501 patient AML complete Study 311-10-001 judge relapse inspection end study .</brief_summary>
	<brief_title>Study OCV-501 Patients With Acute Myeloid Leukemia ( AML ) ( Extension From Study 311-10-001 )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Patients complete Study 31110001 judge relapse inspection end study . Patients capable give informed consent Patients fail discontinue Study 31110001 even though patient meet discontinuation criterion . Patients participate clinical trial , exclude Study 31110001 ) .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acute myeloid leukemia</keyword>
	<keyword>WT1</keyword>
</DOC>